Trademark applications and grants for Arch Development Corp. Arch Development Corp has 6 trademark applications. The latest application filed is for "MARC - THE CREDITOR'S ASSISTANT"
Patent Application | Date |
---|---|
TREATMENT OF TUMORS WITH GENETICALLY ENGINEERED HERPES VIRUS 20130039890 - 13/656195 Weichselbaum; Ralph R. ;   et al. | 2013-02-14 |
Methods for Identifying Factors That Control the Folding of Amyloid Proteins of Diverse Origin 20120135435 - 12/854608 Lindquist; Susan | 2012-05-31 |
DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORS 20110053240 - 12/903706 KUFE; Donald ;   et al. | 2011-03-03 |
Treatment of tumors with genetically engineered herpes virus 20110002890 - 12/802443 Weichselbaum; Ralph R. ;   et al. | 2011-01-06 |
Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors 20060251626 - 11/449778 Leiden; Jeffrey M. ;   et al. | 2006-11-09 |
NCAGE Code | 4Z2Q6 | ARCH DEVELOPMENT CORP |
CAGE Code | 4Z2Q6 | ARCH DEVELOPMENT CORP |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.